Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FCMXT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,817
Award facts
- Contract value 100% obligated
- $32,816.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order valued at $32,816.60 from the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Keytruda 100 mg/4 ml vials. The contract carries an ultimate completion date of September 4, 2025, and was awarded without set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 through November 2026, which enables the agency to procure pharmaceutical products supporting military health facilities worldwide.
Keytruda is a monoclonal antibody immunotherapy used in oncology treatment regimens. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its IDC with the DLA to provide comprehensive pharmaceutical distribution services, including branded and generic prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities. The company's sustained performance in delivering specialized pharmaceutical products demonstrates its established role in supporting military medical readiness and healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FCMXT?
SPE2DB25FCMXT was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FCMXT worth?
The government has obligated $32,817 on SPE2DB25FCMXT.
Is contract SPE2DB25FCMXT an order under another contract?
Yes. SPE2DB25FCMXT is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMXT competed?
The extent of competition for SPE2DB25FCMXT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award